Shanghai Medicilon Inc Cash Flow-to-Debt Ratio
Shanghai Medicilon Inc cash flow-to-debt ratio. Shanghai Medicilon Inc (688202) has a Cash Flow-to-Debt Ratio of -0.02x as of June 2023, meaning its operating cash flow of CN¥-17.10 Million could theoretically repay 0% of its total liabilities (CN¥860.98 Million) in one year. Check 688202 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shanghai Medicilon Inc (2016–2025)
Cash flow-to-debt ratio of Shanghai Medicilon Inc from 2016 to 2025. Historical debt coverage capacity for Shanghai Medicilon Inc across 10 annual periods. Check how aggressively does Shanghai Medicilon Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Shanghai Medicilon Inc Cash Flow-to-Debt Ratio by Year (2016–2025)
Shanghai Medicilon Inc cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Shanghai Medicilon Inc. For the full cash flow conversion analysis, see Shanghai Medicilon Inc cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥105.17 Million | CN¥687.85 Million | ▲ +559.2% |
| 2024 | -0.03x | CN¥-22.75 Million | CN¥683.10 Million | ▼ -175.5% |
| 2023 | 0.04x | CN¥33.32 Million | CN¥755.07 Million | ▲ +250.4% |
| 2022 | -0.03x | CN¥-21.33 Million | CN¥726.80 Million | ▼ -103.0% |
| 2021 | 0.97x | CN¥452.94 Million | CN¥466.06 Million | ▲ +7.0% |
| 2020 | 0.91x | CN¥207.77 Million | CN¥228.67 Million | ▲ +99.1% |
| 2019 | 0.46x | CN¥58.30 Million | CN¥127.73 Million | ▼ -19.7% |
| 2018 | 0.57x | CN¥71.11 Million | CN¥125.06 Million | ▼ -22.1% |
| 2017 | 0.73x | CN¥74.70 Million | CN¥102.29 Million | ▲ +111.4% |
| 2016 | 0.35x | CN¥34.13 Million | CN¥98.81 Million | — |